Gag-Specific Cellular Immunity Determines In Vitro Viral Inhibition and In Vivo Virologic Control following Simian Immunodeficiency Virus Challenges of Vaccinated Rhesus Monkeys

A comprehensive vaccine for human immunodeficiency virus type 1 (HIV-1) would block HIV-1 acquisition as well as durably control viral replication in breakthrough infections. Recent studies have demonstrated that Env is required for a vaccine to protect against acquisition of simian immunodeficiency...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Stephenson, Kathryn E., Li, Hualin, Walker, Bruce D., Michael, Nelson L., Barouch, Dan H.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2012
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3446565/
https://ncbi.nlm.nih.gov/pubmed/22761379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00996-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars